SCHEMBL7786217

SCHEMBL7786217

N=C(N)Nc1cccc(S(=O)(=O)Nc2cccc(C(CC(=O)O)NC(=O)c3ccc(Cl)c(Cl)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.46
MEN1 O00255 7/20 0.46
ALDH1A1 P00352 1/20 0.46
ITGB3 P05106 2/20 0.45
ITGA2B P08514 1/20 0.45
LMNA P02545 4/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PKM P14618 1/20 0.40
GAA P10253 1/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
CTSA P10619 1/20 0.39
ITGAV P06756 1/20 0.39
MAPK1 P28482 1/20 0.39
S1PR3 Q99500 2/20 0.39
CASP3 P42574 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786246 0.91 ITGB3 (0.46) KMT2AMEN1ALDH1A1ITGB3ITGA2B
SCHEMBL7194908 0.89 ITGB3 (0.51) KMT2AMEN1ITGB3ITGA2BLMNA
SCHEMBL7788754 0.88 ITGB3 (0.51) KMT2AMEN1ITGB3ITGA2BPKM
SCHEMBL7790184 0.88 MEN1 (0.48) KMT2AMEN1ITGB3ITGA2BLMNA
SCHEMBL7789975 0.88 ITGB3 (0.46) KMT2AMEN1ITGB3ITGA2BLMNA
SCHEMBL7781212 0.88 ITGB3 (0.48) KMT2AMEN1ITGB3ITGA2BMAPT
SCHEMBL7790080 0.87 MEN1 (0.52) KMT2AMEN1ITGB3ITGA2BSMN1; SMN2
SCHEMBL7781187 0.86 GAA (0.47) KMT2AMEN1ITGB3ITGA2BLMNA
SCHEMBL7785662 0.86 MAPT (0.48) KMT2AMEN1ALDH1A1ITGB3ITGA2B
SCHEMBL7785609 0.86 LMNA (0.45) KMT2AMEN1ALDH1A1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed